McEvoy Ashley
SEC CIK 1745936 · EDGAR
BoughtSold
Most active insiders at PG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moeller Jon R | Exec. COB, Dir | — | $29.90M |
| 2 | Pritchard Marc S. | Chief Brand Off | — | $15.08M |
| 3 | Coombe Gary A | CEO - Grooming | — | $6.40M |
| 4 | Aguilar Moses Victor Javier | Chf Rsch, Dev, Innov Off | — | $3.34M |
| 5 | Purushothaman Balaji | CHRO | — | $2.42M |
| 6 | Whaley Susan Street | CLO, Secy | — | $2.22M |
| 7 | Francisco Ma. Fatima | CEO - Baby, Fem, Family Care | — | $2.18M |
| 8 | Jejurikar Shailesh | COO, Dir | — | $1.49M |
| 9 | Schulten Andre | CFO | — | $1.42M |
| 10 | Raman Sundar G. | CEO-Fabric, Home Care | — | $491.3K |
| 20 | McEvoy Ashley | Dir | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 14:34 | 2026-09-08 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +207 | 6,228 | +3% | $0 | |
| 2026-08-24 07:08 | 2026-08-21 | PODD | Insulet Corporation | McEvoy Ashley | Pres, CEO, Dir | P - Purchase | $147.47 | +1,100 | 23.7K | +5% | +$162.2K | |
| 2026-06-10 14:26 | 2026-06-09 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +202 | 5,986 | +3% | $0 | |
| 2026-05-15 16:21 | 2026-05-13 | PODD | Insulet Corporation | McEvoy Ashley | Pres, CEO, Dir | F - Tax | $148.84 | -1,411 | 22.6K | -6% | -$210.0K | |
| 2026-03-11 | 2026-03-10 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +161 | 5,751 | +3% | $0 | |
| D | 2026-02-26 | 2026-02-24 | PODD | Insulet Corporation | McEvoy Ashley | Pres, CEO, Dir | A - Grant | $0.00 | +10.0K | 24.0K | +72% | $0 |
| 2026-02-23 | 2026-02-20 | PODD | Insulet Corporation | McEvoy Ashley | Pres, CEO, Dir | P - Purchase | $239.35 | +4,300 | 13.9K | +45% | +$1.03M | |
| 2025-12-10 | 2025-12-09 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +215 | 5,563 | +4% | $0 | |
| 2025-10-15 | 2025-10-14 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +1,475 | 5,318 | +38% | $0 | |
| 2025-09-10 | 2025-09-09 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +189 | 3,843 | +5% | $0 | |
| 2025-06-11 | 2025-06-10 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +185 | 3,636 | +5% | $0 | |
| D | 2025-05-15 | 2025-05-13 | PODD | Insulet Corporation | McEvoy Ashley | Pres, CEO, Dir | A - Grant | $0.00 | +9,540 | 9,540 | New | $0 |
| 2025-03-12 | 2025-03-11 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +145 | 3,434 | +4% | $0 | |
| 2024-12-11 | 2024-12-10 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +175 | 3,273 | +6% | $0 | |
| 2024-10-09 | 2024-10-08 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +1,309 | 3,083 | +74% | $0 | |
| 2024-09-11 | 2024-09-10 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +169 | 1,774 | +11% | $0 | |
| 2024-06-12 | 2024-06-11 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +180 | 1,597 | +13% | $0 | |
| 2024-03-13 | 2024-03-12 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +155 | 1,409 | +12% | $0 | |
| 2023-12-14 | 2023-12-12 | PG | Procter & Gamble | McEvoy Ashley | Dir | A - Grant | $0.00 | +1,247 | 1,247 | New | $0 | |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | D - Sale to Iss | $0.00 | -2,787 | 52.0K | -5% | $0 | |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | A - Grant | $0.00 | +18.0K | 62.0K | +41% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | F - Tax | $162.01 | -7,158 | 54.8K | -12% | -$1.16M |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | M - OptEx | $0.00 | +2,999 | 44.8K | +7% | $0 |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | F - Tax | $162.08 | -823 | 44.0K | -2% | -$133.4K |
| D | 2022-12-02 16:32 | 2022-11-30 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | M - OptEx | $72.54 | +73.3K | 115.1K | +175% | +$5.32M |
| DM | 2022-12-02 16:32 | 2022-11-30 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, MedTech | S - Sale+OE | $175.47 | -73.3K | 41.8K | -64% | -$12.87M |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, Medical Devices | M - OptEx | $0.00 | +15.8K | 48.1K | +49% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, Medical Devices | F - Tax | $165.89 | -6,242 | 41.8K | -13% | -$1.04M |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, Medical Devices | M - OptEx | $0.00 | +2,885 | 33.0K | +10% | $0 |
| D | 2022-02-15 20:03 | 2022-02-14 | JNJ | Johnson & Johnson | McEvoy Ashley | EVP, WW COB, Medical Devices | F - Tax | $168.85 | -792 | 32.2K | -2% | -$133.7K |
Purchase Sale Sale after option exercise All abbreviations